| Efficacy of rituximab in 164 patients with biopsy-proven lupus nephritis: pooled data from European cohorts C Díaz-Lagares, S Croca, S Sangle, EM Vital, F Catapano, ... Autoimmunity reviews 11 (5), 357-364, 2012 | 283 | 2012 |
| Systemic involvement in primary Sjögren’s syndrome evaluated by the EULAR-SS disease activity index: analysis of 921 Spanish patients (GEAS-SS Registry) M Ramos-Casals, P Brito-Zeron, R Solans, MT Camps, A Casanovas, ... Rheumatology 53 (2), 321-331, 2014 | 264 | 2014 |
| Systemic activity and mortality in primary Sjögren syndrome: predicting survival using the EULAR-SS Disease Activity Index (ESSDAI) in 1045 patients P Brito-Zeron, B Kostov, R Solans, G Fraile, C Suárez-Cuervo, ... Annals of the rheumatic diseases 75 (2), 348-355, 2016 | 205 | 2016 |
| Characterization and risk estimate of cancer in patients with primary Sjögren syndrome P Brito-Zerón, B Kostov, G Fraile, D Caravia-Durán, B Maure, FJ Rascón, ... Journal of hematology & oncology 10, 1-12, 2017 | 153 | 2017 |
| Rates of, and risk factors for, severe infections in patients with systemic autoimmune diseases receiving biological agents off-label C Díaz-Lagares, R Pérez-Alvarez, FJ García-Hernández, ... Arthritis research & therapy 13, 1-10, 2011 | 85 | 2011 |
| Off-label use of rituximab for systemic lupus erythematosus in Europe M Rydén-Aulin, D Boumpas, I Bultink, JLC Rubio, L Caminal-Montero, ... Lupus science & medicine 3 (1), e000163, 2016 | 70 | 2016 |
| The model for end‐stage liver disease score is the best prognostic factor in human immunodeficiency virus 1–infected patients with end‐stage liver disease: a prospective cohort … J Murillas, A Rimola, M Laguno, E de Lazzari, J Rascón, F Agüero, ... Liver Transplantation 15 (9), 1133-1141, 2009 | 44 | 2009 |
| How are we treating our systemic patients with primary Sjögren syndrome? analysis of 1120 patients H Gheitasi, B Kostov, R Solans, G Fraile, C Suárez-Cuervo, A Casanovas, ... International immunopharmacology 27 (2), 194-199, 2015 | 27 | 2015 |
| Clinical characterization and outcomes of 85 patients with neurosarcoidosis M Ramos-Casals, R Pérez-Alvarez, B Kostov, R Gómez-de-la-Torre, ... Scientific Reports 11 (1), 13735, 2021 | 22 | 2021 |
| Systemic phenotype of sarcoidosis associated with radiological stages. Analysis of 1230 patients R Pérez-Alvarez, P Brito-Zerón, B Kostov, C Feijoo-Massó, G Fraile, ... European journal of internal medicine 69, 77-85, 2019 | 20 | 2019 |
| Coexistence of immune-mediated diseases in sarcoidosis. Frequency and clinical significance in 1737 patients P Brito-Zerón, R Pérez-Alvarez, C Feijoo-Massó, B Gracia-Tello, ... Joint Bone Spine 88 (6), 105236, 2021 | 19 | 2021 |
| Biologics use in SLE in 23 Centers-Data from the International Registry for Biologics In SLE (IRBIS) RF Van Vollenhoven, S Jacobsen, D Wallace, JG Hanly, M Petri, ... 2011 ACR/ARHP Annual Meeting, S235-S235, 2011 | 7 | 2011 |
| The model for end-stage liver disease score is the best prognostic factor in HIV-1-infected patients with end-stage liver disease: a prospective cohort study J Murillas, A Rimola, M Laguno, E de Lazzari, J Rascon, F Aguero Liver Transpl 15, 1133-1141, 2009 | 6 | 2009 |
| Biologics use in sle in 23 centers–data from the international registry for biologics in SLE RF Van Vollenhoven, S Jacobsen, D Wallace, JG Hanly, M Petri, ... Annals of the Rheumatic Diseases 71 (Suppl 1), A9-A9, 2012 | 1 | 2012 |
| Sarcoidosis as a Systemic Disease. Clinical and Epidemiological Characterization of Systemic Phenotype in 1521 Patients S Retamozo, R Perez-Alvarez, C Feijoo-Masso, B De Escalante, ... Wiley, 2019 | | 2019 |
| Musculoskeletal Sarcoidosis: Characterization and Clinical Expression of 129 Patients with Granulomatous Infiltration of Bones And/or Muscles S Retamozo, R Perez-Alvarez, E Bueno Juana, C Feijoo-Masso, ... Wiley, 2019 | | 2019 |
| SAT0596 Thoracic involvement at diagnosis drives a differentiated clinical presentation of sarcoidosis: analysis of 1245 patients (SARCOGEAS-SEMI) S Retamozo, P Brito-Zerón, R Pérez-Alvarez, B Kostov, CF Masso, ... Annals of the Rheumatic Diseases 77 (Suppl 2), 1151-1151, 2018 | | 2018 |
| Off-label use of rituximab for systemic lupus erythematosus in Europe L Saez-Comet, GS Cervello, GD Sebastiani, D Squatrito, G Szucs, ... | | 2016 |
| Criterios serológicos diagnósticos en las vasculitis LP Ferreres, MRJ Benique, EE Marcos, JR Risco Medicine: Programa de Formación Médica Continuada Acreditado 10 (31), 2111-2113, 2009 | | 2009 |
| Uso de las terapias biológicas en las enfermedades autoinmunes sistémicas LP Ferreres, EE Marcos, JR Risco Medicina balear 23 (3), 32-36, 2008 | | 2008 |
